A/Professor Nick Huntington
Prof. Huntington is an NHMRC fellow and head of Cancer Immunology at Biomedicine Discovery Institute, Monash University and honorary researcher at Walter and Eliza Hall Institute of Medical Research.
Prof. Huntington is co-founder and chief scientific advisor of oNKo-Innate Pty Ltd and acts a project director and scientific advisor for numerous industry funded immuno-oncology drug development programs.
He is an international leader on natural killer (NK) cell biology and his most notably contributions include; regulatory mechanisms of IL-15 signalling in NK cells, identification of human and murine NK cell differentiation pathways, novel xenograft models to study human NK cell biology, human NK cell genome editing and identification of multiple checkpoint in NK cell activation and tumour immunity.
Prof. Huntington leads a research program aimed at deciphering the regulatory networks that control NK cell development and homeostasis and a drug discovery program using cutting-edge in vivo screens for novel checkpoints in NK cell activation for targeting in cancer immunotherapy.